Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death

Yingfei Wang1, No Soo Kim, Jean-Francois Haince

  • 1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Science Signaling
|April 7, 2011
PubMed

Insights

Poly(ADP-ribose) (PAR) binding to the mitochondrial protein apoptosis-inducing factor (AIF) is essential for PARP-1-mediated cell death. This interaction triggers AIF release from mitochondria, initiating parthanatos.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitochondrial protein apoptosis-inducing factor (AIF) is involved in poly(ADP-ribose) polymerase-1 (PARP-1)-mediated cell death (parthanatos).
  • AIF is released from mitochondria and translocates to the nucleus during parthanatos.

Purpose of the Study:

  • To investigate the role of poly(ADP-ribose) (PAR) binding in AIF-mediated cell death.
  • To elucidate the mechanism by which PARP-1 activation initiates AIF release and subsequent cell death.

Main Methods:

  • Biochemical assays to determine AIF's PAR-binding affinity and site.
  • In vitro and in vivo experiments using wild-type and mutant AIF.
  • Analysis of AIF's mitochondrial release, nuclear translocation, and cell death induction.

Main Results:

  • AIF is a high-affinity PAR-binding protein.
  • PAR binding to AIF is crucial for parthanatos, both in vitro and in vivo.
  • Mutation of the PAR-binding site prevents AIF release from mitochondria and subsequent cell death, without affecting its NADH oxidase or DNA binding activities.

Conclusions:

  • PAR binding to AIF is a key step in initiating PARP-1-mediated cell death.
  • AIF's bioenergetic functions are distinct from its role as a death effector.
  • Targeting the PAR-AIF interaction offers a potential therapeutic strategy for preventing cell death in conditions involving PARP-1 activation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.